George Rathmann Dies

Apr 24, 2012

George Rathmann, Amgen's founding chief executive, has died, reports The New York Times. He was 84. Rathmann led Amgen in the 1980s while it developed what the Times calls "two of the most successful drugs in history" — Epogen and Neupogen. "He was the one who created the company, without any doubt," says Lowell Sears, a former chief financial officer at Amgen.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Breaking News

The Scan

Severity Predictor

23andMe has launched a new tool that estimates someone's risk of developing severe COVID-19 if infected, Bloomberg reports.

Pasteur Ends Vaccine Push

The Guardian reports that Pasteur Institute researchers are halting their development of a SARS-CoV-2 vaccine following disappointing initial results.

Shift Younger

The Wall Street Journal reports that an increased number of younger patients have been hospitalized as the new SARS-CoV-2 strain spread across the UK.

Cell Studies on COVID-19 Autopsy Proteomics, Human Intestinal Development, Macaque Brain Map

In Cell this week: proteomic patterns among COVID-19 affected tissue samples, transcriptome atlas of developing intestines, and more.

Menu